{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:07:27Z","timestamp":1761541647004,"version":"3.37.3"},"reference-count":20,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare complication after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) adenoviral vector vaccination. In British Columbia (BC), Canada, a provincial clinical care pathway was developed to guide clinicians in evaluating for VITT among patients who present with thrombocytopenia or thrombosis symptoms within 4 to 28 days after adenoviral vector vaccine exposure. All patients had enzyme-linked immunosorbent assay (ELISA) testing for platelet factor 4 (PF4) antibodies, and all cases with positive PF4-ELISA or d-dimer levels \u22652.0 mg\/L fibrinogen equivalent units (FEU) had further testing for platelet-activating PF4 antibodies using a modified serotonin release assay (SRA). Between 1 May and 30 June 2021, 37% of 68 patients investigated for VITT had thrombosis, but only 3 had VITT confirmed by PF4-ELISA and SRA. Platelet counts, d-dimer levels, and ELISA optical density values were significantly different between those with and without VITT. Three patients had thrombocytopenia and thrombosis with d-dimer levels &amp;gt;4.0 mg\/L FEU but had negative PF4-ELISA and SRA results. Patients with VITT were treated successfully with IV immunoglobulin, nonheparin anticoagulants, and corticosteroids. Our pathway demonstrated that thrombosis is common among patients investigated for VITT and that PF4-ELISA testing is necessary to confirm VITT in those presenting with thrombosis and thrombocytopenia.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021006862","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T15:26:17Z","timestamp":1654183577000},"page":"3315-3320","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":8,"title":["Clinical care pathway for the evaluation of patients with suspected VITT\u00a0after ChAdOx1 nCoV-19 vaccination"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1915-6681","authenticated-orcid":false,"given":"Agnes Y. Y.","family":"Lee","sequence":"first","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4350-6218","authenticated-orcid":false,"given":"Muntadhar","family":"Al Moosawi","sequence":"additional","affiliation":[{"name":"2Department of Pathology and Laboratory Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica A.","family":"Peterson","sequence":"additional","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2962-0364","authenticated-orcid":false,"given":"Rita K.","family":"McCracken","sequence":"additional","affiliation":[{"name":"3Department of Family Practice, University of British Columbia, Vancouver, BC, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven K. W.","family":"Wong","sequence":"additional","affiliation":[{"name":"4Department of Pathology and Laboratory Medicine, St Paul\u2019s Hospital, Vancouver, BC, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamish","family":"Nicolson","sequence":"additional","affiliation":[{"name":"2Department of Pathology and Laboratory Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicky","family":"Chan","sequence":"additional","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0015-8337","authenticated-orcid":false,"given":"Tyler","family":"Smith","sequence":"additional","affiliation":[{"name":"2Department of Pathology and Laboratory Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle P.","family":"Wong","sequence":"additional","affiliation":[{"name":"2Department of Pathology and Laboratory Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren J.","family":"Lee","sequence":"additional","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron","family":"Griffiths","sequence":"additional","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavdeep","family":"Rahal","sequence":"additional","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3232-5574","authenticated-orcid":false,"given":"Stephen","family":"Parkin","sequence":"additional","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Afra","sequence":"additional","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberley","family":"Ambler","sequence":"additional","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9551-2951","authenticated-orcid":false,"given":"Luke Y. C.","family":"Chen","sequence":"additional","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1176-0633","authenticated-orcid":false,"given":"Thalia S.","family":"Field","sequence":"additional","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather C.","family":"Lindsay","sequence":"additional","affiliation":[{"name":"5Department of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Lavoie","sequence":"additional","affiliation":[{"name":"6Office of the Provincial Health Officer, Ministry of Health, Government of British Columbia, Victoria, BC, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Li","sequence":"additional","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7242-0739","authenticated-orcid":false,"given":"David","family":"Migneault","sequence":"additional","affiliation":[{"name":"5Department of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4947-6208","authenticated-orcid":false,"given":"Monika","family":"Naus","sequence":"additional","affiliation":[{"name":"7BC Centre for Disease Control, Vancouver, BC, Canada;"},{"name":"8School of Population and Public Health, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanta","family":"Piszczek","sequence":"additional","affiliation":[{"name":"9Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poupak","family":"Rahmani","sequence":"additional","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayatri","family":"Sreenivasan","sequence":"additional","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9820-1446","authenticated-orcid":false,"given":"Tony","family":"Wan","sequence":"additional","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Yee","sequence":"additional","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Zypchen","sequence":"additional","affiliation":[{"name":"1Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Sweet","sequence":"additional","affiliation":[{"name":"5Department of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"issue":"22","key":"2022060215234906400_B1","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med."},{"issue":"22","key":"2022060215234906400_B2","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med."},{"issue":"24","key":"2022060215234906400_B3","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2021.7517","article-title":"US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021","volume":"325","author":"See","year":"2021","journal-title":"JAMA."},{"issue":"23","key":"2022060215234906400_B4","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Engl J Med."},{"issue":"18","key":"2022060215234906400_B5","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N Engl J Med."},{"year":"2021","key":"2022060215234906400_B6"},{"year":"2021","author":"Brighton Collaboration","key":"2022060215234906400_B7"},{"year":"2021","author":"World Health Organization","key":"2022060215234906400_B8"},{"year":"2021","author":"American Society of Hematology","key":"2022060215234906400_B9"},{"year":"2021","author":"International Society on Thrombosis and Haemostasis","key":"2022060215234906400_B10"},{"year":"2021","key":"2022060215234906400_B11"},{"key":"2022060215234906400_B12","first-page":"161","article-title":"COVID-19 pharmaologic therapy guidance for BC","volume":"62","author":"British Columbia COVID-19 Therapeutics Committee","year":"2020","journal-title":"BCMJ."},{"issue":"7","key":"2022060215234906400_B13","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1111\/jth.15346","article-title":"Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT)","volume":"19","author":"Thaler","year":"2021","journal-title":"J Thromb Haemost."},{"issue":"8","key":"2022060215234906400_B14","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/jth.15362","article-title":"Evaluation of laboratory assays for anti-platelet factor 4 antibodies after ChAdOx1 nCOV-19 vaccination","volume":"19","author":"Platton","year":"2021","journal-title":"J Thromb Haemost."},{"issue":"4","key":"2022060215234906400_B15","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1056\/NEJMc2106383","article-title":"PF4 Immunoassays in vaccine-induced thrombotic thrombocytopenia","volume":"385","author":"Vayne","year":"2021","journal-title":"N Engl J Med."},{"issue":"8","key":"2022060215234906400_B16","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa2107051","article-title":"Adjunct immune globulin for vaccine-induced immune thrombotic thrombocytopenia","volume":"385","author":"Bourguignon","year":"2021","journal-title":"N Engl J Med."},{"issue":"1114","key":"2022060215234906400_B17","doi-asserted-by":"crossref","first-page":"n1114","DOI":"10.1136\/bmj.n1114","article-title":"Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study","volume":"373","author":"Potteg\u00e5rd","year":"2021","journal-title":"BMJ."},{"key":"2022060215234906400_B18","doi-asserted-by":"crossref","first-page":"n1931","DOI":"10.1136\/bmj.n1931","article-title":"Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study","volume":"374","author":"Hippisley-Cox","year":"2021","journal-title":"BMJ."},{"year":"2021","author":"Chan","key":"2022060215234906400_B19"},{"year":"2021","key":"2022060215234906400_B20"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/11\/3315\/1899932\/advancesadv2021006862.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/11\/3315\/1899932\/advancesadv2021006862.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T15:26:28Z","timestamp":1654183588000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/11\/3315\/484151\/Clinical-care-pathway-for-the-evaluation-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,6,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021006862","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"type":"print","value":"2473-9529"},{"type":"electronic","value":"2473-9537"}],"subject":[],"published":{"date-parts":[[2022,6,2]]}}}